Latest posts tagged with #Drugrepurposing on Bluesky
AGENDA TOPICS:
- Bayesian & Adaptive Trial Designs
- Alternatives to Placebos & Randomized Controls in #ClinicalTrials
- Funding #RareDisease Research
- #FDA Plausible Mechanism
- Abandoned, Shelved & Rescued Therapies
- #DrugRepurposing
- Endpoint Selection
- Registries & Real-World Data
- And more
When we say we're building a global #DrugRepurposing community, we mean it.
Over 50 academic institutions, private organisations and EU-funded initiatives from 20 countries have already joined our mission!
Meet the innovators making precision therapies a reality for patients 💊 repo4.eu/community/
Research is exploring how Ivermectin may interact with cancer biology, but it is not an approved treatment.
More studies are needed to confirm safety and effectiveness.
#Ivermectin #CancerResearch #Oncology
#Ivermectin #CancerResearch #DrugRepurposing #Oncology #MedicalScience
A survey of 197 cancer patients using ivermectin and mebendazole reported:
84.4% improvement | 32.8% no disease | 15.6% tumor reduction
These findings echo broader patient-reported outcomes and highlight growing interest in drug repurposing.
#Ivermectin #CancerResearch #Oncology #DrugRepurposing
This review highlights the repositioning of #Albendazole from an #Anthelmintic to an #Anticancer agent, with demonstrated applications across diverse malignancies, and underscores the broader promise of #DrugRepurposing in #Oncology.
Meet our #DrugRepurposing Community member 💊
Prestwick Chemical Libraries (by Laboratoire Greenpharma), the French medicinal chemistry services provider focused on accelerating small molecules for drug discovery.
Find out more ⤵️
repo4.eu/community-me...
Join the Medicines Reimagined Stakeholder Forum, a collaborative space bringing together researchers, policy-makers, funders, and patient advocates to advance #DrugRepurposing.
👉 Join the conversation today: https://remedi4all.org/stakeholder-forum
An inexpensive FDA-approved epilepsy drug could block toxic proteins decades before symptoms appear, reframing prevention in brain aging.
vist.ly/4uu4a
#longevity #Alzheimers #BrainHealth #Neuroscience #DrugRepurposing #Neurodegeneration #HealthyAging
Synapse: Your Connection to our MSK Authors
Meet: Sophia Meixuan Zhang
Research Focus: SKI-Pediatrics; Research Tech
Prompt-based multimodal representation learning for drug repurposing
synapse.mskcc.org/synapse/work...
#DrugRepurposing #AIinMedicine
#MultimodalAI #MachineLearning
#DeepLearning
Meet our #DrugRepurposing Community member 💊 BioMatch, the AI-powered platform helping biotech startups discover new applications for their technologies.
Welcome to our global community of innovators shaping the future of #Medicine!
Find out more ⤵️
repo4.eu/community-me...
On 17 March, we'll be in Brussels to explore the latest advances in #DrugRepurposing and explore collaborative opportunities in the region 💊
Check out the full agenda and meet the speakers joining us on the day: repo4.eu/national-eve...
@hhhwschmidt.bsky.social @scienceinnovation.ec.europa.eu
Clinical trial funding available for #LMICs: apply by Apr 10. Up to 9 #ClinicalTrials testing generic, approved therapies impacting high disease burden to be selected, US$70K each. Info: bit.ly/cwrrfps. Help spread the word! #DrugRepurposing #ImpactPhilanthropy #GlobalHealth
🔍 New Early Career Researcher Insights!
We spoke with Maria Kuzikov, Senior Scientist at Fraunhofer Institute in Hamburg, about her work, background and vision for #DrugRepurposing.
➡️ Full interview: https://loom.ly/KOlixtQ
📣 New Medicines Reimagined Story - Obinutuzumab: From Cancer to Lupus. Each month, we showcase how how new uses have been found for existing medicines through #DrugRepurposing
➡️ Read more about how this innovation was brought to life here: https://loom.ly/4Qp4-yg
REPO4EU On Tour: Brussels
REPO4EU On Tour 2026: Brussels 🇧🇪
Join our next National Dissemination Event in Brussels on 17 March to explore the latest advances in #DrugRepurposing in the region 👉 repo4.eu/national-eve...
@hhhwschmidt.bsky.social @ruweee.bsky.social @steelarm.bsky.social @scienceinnovation.ec.europa.eu
REPO4EU On Tour 2026: Nicosia 🇨🇾
On 6th March we're hosting a National Dissemination Event in Nicosia with The Cyprus Institute of Neurology & Genetics.
Come and explore the latest advances in #DrugRepurposing in the region 👉 repo4.eu/national-eve...
@hhhwschmidt.bsky.social
💻 #REMEDi4ALL Funders Network Webinar: Working with Regulators: Pre-grant scientific advice
Funders & regulators discuss why pre‑grant regulatory scientific advice (PGRSA) matters for #DrugRepurposing, with real case studies + insights from IncreaseNET.
🔗 Materials: https://loom.ly/ZTiu4mQ
REPO4EU partners speaking at Infinite 2026: Alexander Scheer (BioLizard) and Emre Guney (STALICLA)
Our partners Alexander Scheer (BioLizard) and Emre Guney (STALICLA) will be speaking at #Infinite2026, the event hosted by DeepLife to explore the role of AI in #DrugRepurposing 💊
Join them and other industry leaders - for free!
🎟️ luma.com/pudccgwc
#AspirinCancer
🧬 Drug Repurposing: Aspirin may target cancer stem cells, cut resistance, and boost chemo.
⚠️ Risks: Not proven for all; some studies show higher cancer death risk in older adults.
#AspirinCancer #DrugRepurposing #AspirinRisks
View in Timelines
Three Everyday Drugs Could Be Repurposed To Prevent Alzheimer’s #Science #HealthandMedicine #Neurology #AlzheimersResearch #DrugRepurposing #NeurodegenerativeDiseases
scitechdaily.com/three-everyday-drugs-cou...
An image of the Eiffel Tower with text overlaid that says: REPO4EU on Tour: Paris, 19th February 2026, online and in-person. Funded by the European Union.
Our upcoming National Dissemination Event in Paris is quickly approaching! 🇫🇷
Join us on 19th February, in-person or online, to learn all about #DrugRepurposing efforts in France and across Europe.
Register for free 👉 luma.com/oh9hr838
@hhhwschmidt.bsky.social @scienceinnovation.ec.europa.eu
Join the 'Medicines Reimagined' Forum, where enthusiasts and experts in drug repurposing unite! Connect, collaborate, share insights, and explore the challenges and successes in the #DrugRepurposing field.
👉 Join the dialogue today: https://remedi4all.org/stakeholder-forum
📣 Learn from the diverse strategies and approaches in #DrugRepurposing at #iDR26!
Join us to connect, share knowledge, and navigate the future of medicines repurposing.
🔗 Learn more and register for an early bird ticket by 31 Jan here: https://loom.ly/9dw7qdk
New research paper: Navigating the computational landscape for drug repurposing.
Check out the latest study conducted by #REPO4EU researchers 💊 'Navigating the Computational Landscape for #DrugRepurposing'
Published by @annualreviews.bsky.social ➡️ annualreviews.org/content/jour...
@upm.es @neurologieessen.bsky.social @maastrichtu.bsky.social
#EUfunded #EU4Health #HaDEA
Join us in Paris on 19th February to enjoy a full day at the forefront of AI-driven biology, where established therapies meet cutting-edge technology to address unmet medical needs faster and more efficiently than ever before.
Register now 👉 repo4.eu/national-eve...
#DrugRepurposing #EUfunded
REPO4EU On Tour: Paris - 19 February, online and in-person. Meet the speakers.
On 19 February we'll be in Paris to explore the latest advances in #DrugRepurposing and explore collaborative opportunities in the region 💊 🇫🇷
Check out the full agenda: repo4.eu/national-eve...
And scroll down this thread to meet the experts joining us on the day 👇
Pleased to share our brief commentary on how antiplatelet drugs such as ticagrelor (Brilinta) may have an intriguing beneficial action toward effective treatment of Staphylococcus aureus bacteremia and endovascular infection
#drugrepurposing
Papers continuing to come from one of the best collaborations of my career. Hoping to make a difference for women with #ovariancancer taking #DrugRepurposing approaches. Kudos to 1st & last authors & all of us in the middle. A joyful collaboration on all levels. journals.sagepub.com/doi/10.1177/...
Congratulations to @cureid.bsky.social @idepiheather.bsky.social (Heather Stone) and team for publication: CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic Disorders
onlinelibrary.wiley.com/doi/10.1002/...
#DrugRepurposing #RareDisease
Dengue affects millions, yet we still lack a specific antiviral cure. Management is often just "wait and support."
doi.org/10.52711/097...
#WeiPublications #Dengue #InfectiousDiseases #GlobalHealth #MedSky #PublicHealth #DrugRepurposing #Pharmacology #FOAMed
